ATE143801T1 - Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und verfahren zur herstellung derselben - Google Patents

Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und verfahren zur herstellung derselben

Info

Publication number: ATE143801T1
Authority: AT; Austria
Prior art keywords: active substance; composition; pct; producing; same
Prior art date: 1992-07-03

Application number

AT93916292T

Other languages

English (en)

Inventor

Arie Cornelis Besemer

Coenraad Ferdinand Lerk

Original Assignee

Tno

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-07-03

Filing date

1993-07-02

Publication date

1996-10-15

1993-07-02 Application filed by Tno filed Critical Tno

1996-10-15 Application granted granted Critical

1996-10-15 Publication of ATE143801T1 publication Critical patent/ATE143801T1/de

Links

239000013543 active substance Substances 0.000 title abstract 6
238000004519 manufacturing process Methods 0.000 title 1
229920000310 Alpha glucan Polymers 0.000 abstract 1
229920000856 Amylose Polymers 0.000 abstract 1
229920001503 Glucan Polymers 0.000 abstract 1
GUBGYTABKSRVRQ-ASMJPISFSA-N alpha-maltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-ASMJPISFSA-N 0.000 abstract 1
230000003111 delayed effect Effects 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
150000004676 glycans Chemical class 0.000 abstract 1
239000011159 matrix material Substances 0.000 abstract 1
229920001282 polysaccharide Polymers 0.000 abstract 1
239000005017 polysaccharide Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Polysaccharides And Polysaccharide Derivatives (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

AT93916292T 1992-07-03 1993-07-02 Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und verfahren zur herstellung derselben ATE143801T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
NL9201195A NL9201195A (nl)	1992-07-03	1992-07-03	Preparaat voor de gereguleerde afgifte van een werkzame stof en werkwijze ter bereiding van een dergelijk preparaat.

Publications (1)

Publication Number	Publication Date
ATE143801T1 true ATE143801T1 (de)	1996-10-15

Family

ID=19861014

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93916292T ATE143801T1 (de)	1992-07-03	1993-07-02	Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und verfahren zur herstellung derselben

Country Status (12)

Country	Link
US (1)	US5585114A (de)
EP (1)	EP0648116B1 (de)
JP (1)	JPH07508533A (de)
AT (1)	ATE143801T1 (de)
AU (1)	AU678166B2 (de)
CA (1)	CA2139494A1 (de)
DE (1)	DE69305346T2 (de)
DK (1)	DK0648116T3 (de)
ES (1)	ES2095658T3 (de)
GR (1)	GR3022195T3 (de)
NL (1)	NL9201195A (de)
WO (1)	WO1994001092A1 (de)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
NL9401572A (nl) *	1994-09-27	1996-05-01	Avebe Coop Verkoop Prod	Zetmeelprodukten als tabletteerhulpstof, werkwijze voor het bereiden daarvan alsmede werkwijze voor het maken van tabletten.
FR2743496B1 (fr) *	1996-01-15	1998-04-10	Univ Rennes	Composite macroporeux support de substance(s) medicamenteuse(s) utilisable comme materiau de reconstitution osseuse et procede d'elaboration
GB9605857D0 (en) *	1996-03-20	1996-05-22	Tester Richard F	Polysaccharides as chemical release systems
US5879707A (en) *	1996-10-30	1999-03-09	Universite De Montreal	Substituted amylose as a matrix for sustained drug release
CA2211778A1 (en) *	1997-08-14	1999-02-14	Francois Carriere	Preparation of pregelatinized high amylose starch and debranched starch useful as an excipient for controlled release of active agents
WO1999030691A2 (en) *	1997-12-18	1999-06-24	Ato B.V.	Composition for the controlled release of active compounds
AP1748A (en)	2001-03-13	2007-06-11	Penwest Pharmaceuticals Co	Chronotherapeutic dosage forms.
JP3742335B2 (ja) *	2001-12-20	2006-02-01	富士通株式会社	入出力バッファ回路
US7081261B2 (en) *	2002-05-14	2006-07-25	National Starch And Chemical Investment Holding Corporation	Resistant starch prepared by isoamylase debranching of low amylose starch
US6929817B2 (en) *	2002-05-14	2005-08-16	National Starch & Chemical Investment Holding Corporation	Slowly digestible starch product
US6890571B2 (en) *	2002-05-14	2005-05-10	National Starch And Chemical Investment Holding Corporation	Slowly digestible starch product
US20040185097A1 (en) *	2003-01-31	2004-09-23	Glenmark Pharmaceuticals Ltd.	Controlled release modifying complex and pharmaceutical compositions thereof
US9101155B2 (en)	2003-07-11	2015-08-11	Asahi Kasei Chemicals Corporation	Functional starch powder
US20070071810A1 (en) *	2003-08-26	2007-03-29	Kenichi Kudo	Additive for tablets
US8389008B2 (en)	2003-09-19	2013-03-05	Penwest Pharmaceuticals Co.	Delayed release dosage forms
KR101377553B1 (ko)	2005-12-09	2014-03-25	에스체아 히기에너 프로덕츠 악티에볼라그	흡수 제품
WO2010048389A2 (en) *	2008-10-23	2010-04-29	Henkel Corporation	Pharmaceutical pellets comprising modified starch and therapeutic applications therefor
US20130172411A1 (en) *	2010-03-22	2013-07-04	Cadila Healthcare Limited	Stable pharmaceutical compositions comprising fesoterodine

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3493652A (en) *	1962-09-14	1970-02-03	Charles W Hartman	Controlled release medicament
GB1072795A (en) *	1963-08-28	1967-06-21	Eastman Kodak Co	Solid composition containing fat-soluble vitamins and processes for making it
US3490742A (en) *	1966-01-14	1970-01-20	Staley Mfg Co A E	Compressed tablets
EP0169893A4 (de) *	1984-01-31	1987-01-22	Scm Corp	Einkapselmatrizenzusammensetzung und diese enthaltendes eingekapseltes erzeugnis.
IT1191674B (it) *	1986-03-07	1988-03-23	Eurand Spa	Formulazioni per la preparazione di farmaci a rilascio prolungato adatte alla somministrazione per via orale
JPH0747539B2 (ja) *	1986-10-22	1995-05-24	東京田辺製薬株式会社	胆汁酸固形製剤
DE3721574A1 (de) *	1987-06-30	1989-01-12	Kettelhack Riker Pharma Gmbh	Arzneimittel in form von pellets mit enzymatisch kontrollierter arzneistoff-freisetzung
GB8812490D0 (en) *	1988-05-26	1988-06-29	Agricultural & Food Res	Delayed release formulations
CA2041774C (en) *	1990-11-27	1994-04-19	Mircea A. Mateescu	Use of cross-linked amylose as a matrix for the slow release of biologically active compounds

1992
- 1992-07-03 NL NL9201195A patent/NL9201195A/nl not_active Application Discontinuation
1993
- 1993-07-02 AU AU45893/93A patent/AU678166B2/en not_active Ceased
- 1993-07-02 EP EP93916292A patent/EP0648116B1/de not_active Expired - Lifetime
- 1993-07-02 DK DK93916292.1T patent/DK0648116T3/da active
- 1993-07-02 WO PCT/NL1993/000140 patent/WO1994001092A1/en not_active Ceased
- 1993-07-02 CA CA002139494A patent/CA2139494A1/en not_active Abandoned
- 1993-07-02 ES ES93916292T patent/ES2095658T3/es not_active Expired - Lifetime
- 1993-07-02 AT AT93916292T patent/ATE143801T1/de not_active IP Right Cessation
- 1993-07-02 JP JP6503185A patent/JPH07508533A/ja active Pending
- 1993-07-02 DE DE69305346T patent/DE69305346T2/de not_active Expired - Fee Related
- 1993-07-02 US US08/356,256 patent/US5585114A/en not_active Expired - Fee Related
1996
- 1996-12-30 GR GR960403674T patent/GR3022195T3/el unknown

Also Published As

Publication number	Publication date
GR3022195T3 (en)	1997-03-31
AU4589393A (en)	1994-01-31
JPH07508533A (ja)	1995-09-21
EP0648116A1 (de)	1995-04-19
CA2139494A1 (en)	1994-01-20
DE69305346D1 (de)	1996-11-14
AU678166B2 (en)	1997-05-22
DE69305346T2 (de)	1997-04-30
EP0648116B1 (de)	1996-10-09
US5585114A (en)	1996-12-17
DK0648116T3 (da)	1997-03-24
ES2095658T3 (es)	1997-02-16
NL9201195A (nl)	1994-02-01
WO1994001092A1 (en)	1994-01-20

Similar Documents

Publication	Publication Date	Title
ATE143801T1 (de)	1996-10-15	Zusammensetzung zur kontrollierten abgabe eines wirkstoffes und verfahren zur herstellung derselben
Zhang et al.	2002	Calcium phosphate/chitosan composite scaffolds for controlled in vitro antibiotic drug release
DE69425671D1 (de)	2000-09-28	Glucosamin-disaccharide, verfahren zu deren herstellung, pharmazeutische präparate davon und ihre verwendung
WO2008025840A2 (de)	2008-03-06	Strukturierte beschichtungen für implantate sowie verfahren zu deren herstellung
EP0814659A4 (de)	2001-03-14	Zusammensetzungen mit kontrollierter freigabe und verfahren zur behandlung von organismen in der umwelt
DE69128621D1 (de)	1998-02-12	Biokeramisches system zur abgabe von bioaktiven stoffen
EP0402031A3 (de)	1991-03-20	Injizierbare polymere Körper
DE69333556D1 (de)	2004-07-22	Injektierbare, keramische Verbindungen sowie Verfahren zu deren Herstellung und Anwendung
US6051560A (en)	2000-04-18	Chrondroitin sulfate/sodium hyaluronate composition
ATE182278T1 (de)	1999-08-15	Teilchen, methode zur herstellung der teilchen und deren verwendung
UA27698C2 (uk)	2000-10-16	Спосіб одержання мікрокапсули поліпептиду
ATE179886T1 (de)	1999-05-15	Pharmazeutische zusammensetzung mit einem schmelzbaren traegermaterial und verfahren zu seiner herstellung
ES8802434A1 (es)	1988-06-01	Un procedimiento para la preparacion de un polisiloxano macromero con grupos polimerizables no saturados.
DE69311404T2 (de)	1997-11-06	Bindemittel und seine Verwendungen
CA2423783A1 (en)	2002-04-04	Inhibition of systemic infections in humans and vertebrates by dietary fibers
ATE145821T1 (de)	1996-12-15	Zusammenfassung zur kontrollierten abgabe eines wirkstoffes und verfahren zur herstellung derselbe
DK0722477T3 (da)	1998-01-12	Vandige polymerisatfremstillinger
ATE246515T1 (de)	2003-08-15	Verfahren zur herstellung von oralen dosierungsformulierungen enthaltend diclofenac
HUT58263A (en)	1992-02-28	Galacto-mannane derivatives for coating and incorporating pharmaceutical active components
MX9709614A (es)	1998-07-31	Composiciones emulsificadas de 1-4-bis(bromoacetoxi)-2-buteno utiles como un microbicida y conservador.
GEP20022840B (en)	2002-11-25	Form VI 5,6-Dichloro-2-(Isopropylamino)-1-(Beta-L-Ribofuranosyl-1H-Benzimidazole), Method for Their Production, Composition for Treating Virus Infections and Methods for Treatment
ATE156842T1 (de)	1997-08-15	Oligosaccharide mit biologischer aktivität und verfahren zur herstellung aus glykosaminoglykanen
Uda et al.	2006	Experimental studies on hydroxyapatite powder-carboxymethyl chitin composite: injectable material for bone augmentation
CA2070803A1 (fr)	1992-04-27	Materiau implantable biodegradable et procede de fabrication
AU635948B2 (en)	1993-04-08	Liquid suspensions of nitrofurantoin

Legal Events

Date	Code	Title	Description
1997-05-15	UEP	Publication of translation of european patent specification
2003-04-15	REN	Ceased due to non-payment of the annual fee